Introduction {#sec0005}
============

Receptors of the innate immune system sense foreign molecules and structures such as the highly conserved microbe-associated molecular patterns (MAMPs) like sugars, lipids, proteins, or nucleic acids of bacteria, fungi or viruses ([@bib0690]). Innate immune receptor stimulation by MAMPs triggers intracellular defense mechanisms and the induction of innate immune responses, including secretion of cytokines and chemokines, which lead to alarming of neighboring cells and attracting immune cells. Most of the known highly pathogenic and emerging viruses are RNA genome-based; they give rise to epidemic and zoonotic diseases (Flu, foot-and-mouth disease) or cause viral hemorrhagic fever including yellow fever, dengue, lassa fever and Ebola ([@bib0080]). The recognition of foreign pathogenic RNA, resulting in induction of type I interferon (IFN), the most important antiviral cytokine, is therefore highly critical.

Innate immune cells express the endosomal Toll-like receptors (TLR) 7, 8 and 9, which sense GU-rich RNA and CpG-containing DNA. TLR stimulation leads to secretion of type-I IFN, IL-12 and assorted chemokines ([@bib0150], [@bib0225], [@bib0230], [@bib0245], [@bib0250], [@bib0290], [@bib0340]), reviewed in ([@bib0035], [@bib0595], [@bib0605]). In contrast to TLR7, 8 and 9, TLR3 is expressed in more cell types (*e.g.* endothelial cells, fibroblasts, astrocytes) ([@bib0035], [@bib0595]) and was found to detect long double-stranded RNA ([@bib0015]). Unlike TLRs, the RIG-I-like receptors (RLR) RIG-I, MDA5 and Lgp2 are present in the cytosol of all cell types. Similar to TLRs, RIG-I and MDA5 induce type I IFN and chemokines (but no IL12) upon activation by viral but also bacterial RNA. While the endosomal RNA detecting TLRs do contribute to antiviral immunity, RLRs are essential for the immune recognition of and response to most RNA viruses ([Fig. 1](#fig0005){ref-type="fig"} ) ([@bib0200], [@bib0240], [@bib0305], [@bib0565], [@bib0720], [@bib0775]). This review summarizes the biological role of and ligand recognition by RLR with special focus on RIG-I, which represents the most broadly studied and understood receptor to date.Fig. 1Viruses recognized by RIG-I and MDA5 and evading RLR recognition. S: segmented, NS: non-segmented, ssRNA: single-stranded RNA, dsRNA: double-stranded RNA, (+): positive strand genome, (−): negative strand genome. \*Recognition by RIG-I and MDA5 in oligodendrocytes ([@bib0355]) but no recognition by RIG-I or MDA5 in BM-DC or fibroblasts ([@bib0795]), recognition by MDA5, not RIG-I in macrophages and microglia ([@bib0560]). \*\*Evasion of RIG-I recognition by nuclease 5′ end cleavage leaving monophosphate at the 5′end of the viral genome ([@bib0190], [@bib0215]). \*\*\*Evasion of RIG-I recognition *via* substitution of 5′triphosphate by Vpg protein at the 5′end of the viral genome ([@bib0255], [@bib0350], [@bib0555]). \*\*\*\*Evasion of RIG-I recognition by overhang at the 5′end of the viral genome ([@bib0435]). Weber, 2013: papers contributing to the characterization of the real ligand structure *in vivo* are underlined.

RIG-I like receptors (RLRs) {#sec0010}
---------------------------

RIG-I (retinoic acid-inducible gene I) and MDA5 (melanoma differentiation-associated gene-5) are closely related DExD/H-box helicase family proteins. They consist of an N-terminal tandem caspase activation and recruitment domain (CARD) fused to a DExD/H-box helicase domain (composed of Hel1, Hel2 and Hel2i) and the C-terminal domain (CTD; previously called RD = repressor domain) ([@bib0405], [@bib0570], [@bib0775]) ([Fig. 2](#fig0010){ref-type="fig"} ). Stimulation of RIG-I or MDA5 by viral RNA release the associated CARDs, which aggregate with K63 polyubiquitin chains to CARD tetramers and then bind and activate the adaptor molecule MAVS ([@bib0285], [@bib0780], [@bib0785]). MAVS (also known as IPS-1, Cardif or VISA ([@bib0310], [@bib0455], [@bib0620], [@bib0765])) recruits TBK-1, which phosphorylates IRF3 to induce transcription of type-I IFN genes ([@bib0155], [@bib0180], [@bib0625]). At present, the interaction of RIG-I with its corresponding ligand RNA is far better understood and analyzed than ligand--receptor interactions of MDA5 or Lgp2. Both the CTD and helicase domain (which is no active RNA helicase) possess RNA binding sites, whereas solely the CTD harbors the critical binding pocket for the RNA ligand, the features of which will be discussed below. As of now, high-resolution structure studies have been performed of the CTD alone ([@bib0130], [@bib0680]), the CTD with ligand ([@bib0390], [@bib0725]), mouse RIG-I SF2 domain + non-hydrolysable ATP ([@bib0125]), human RIG-I(ΔCARDs) + ligand ([@bib0280], [@bib0400]), whole duck RIG-I(ligand free) and helicase + ligand ([@bib0335]). The current model of RIG-I ligand interaction resulting from the above-mentioned studies was extensively discussed ([@bib0325]). Briefly, the CARD of non-stimulated RIG-I binds to the so-called Hel-2i domain within the helicase domain, mediating an auto-inhibited state. Upon stimulation the CTD-bound RNA interacts with Hel-2i, leading to dislocation of the CARDs, which now become accessible for downstream interactions (CARD multimerization, MAVS interaction, type I IFN induction) as described above. A similar activation mechanism for MDA5 is thinkable. But as long as a MDA5 recognition motif has not been clearly defined (discussed below) it remains unclear if the MDA5 CTD mediates ligand specificity.Fig. 2Domain structure of RIG-I, MDA5 and Lgp2.

A recently described crystal structure of MDA5(ΔCARDs) with a synthetic 11mer dsRNA (which is not a MDA5 activating ligand) revealed that the MDA5 CTD does not cap the terminus of the blunt dsRNA but rather binds the internal RNA duplex structure ([@bib0750]). This would provide a prerequisite for a putative MDA5 head-to-tail arrangement in a filament structure with exposed CARDs, which was suggested to be the MAVS activating structure ([@bib0750]).

The third RLR family member Lgp2 lacks CARDs and does not induce type I IFN. Its putative function will be discussed in the next section.

Lgp2--biological role {#sec0015}
---------------------

The role of Lgp2 in the immune response against viruses is not entirely understood. The Lgp2 CTD resembles the RIG-I CTD, albeit with different requirements for ligand binding, which will be discussed below ([@bib0365], [@bib0475], [@bib0525]). While Lgp2 structurally shares a helicase and CTD, it lacks CARDs, suggesting a putative ligand sequestering role. Indeed, initial reports suggested a pure immune suppressive function for Lgp2 ([@bib0330], [@bib0565], [@bib0570], [@bib0775]). Confusingly, a RIG-I-suppressing activity was found to be independent of dsRNA binding ([@bib0365]).

The parainfluenzavirus type 5 V protein was reported to interact with Lgp2, to stabilize a Lgp2/RIG-I complex and in this way to cooperatively inhibit induction by RIG-I ligands ([@bib0110]).

Further studies on Lgp2-deficient mice revealed that Lgp2 absence impairs the immune response to viruses that are mainly detected by MDA5, and can both impair or enhance RIG-I mediated antiviral responses ([@bib0525], [@bib0585], [@bib0720]). [@bib0665] confirmed that Lgp2 contributed to sustained RLR signaling of IFN-β expression in myeloid cells during West Nile virus (WNV) or dengue virus infection. Additionally, they discovered a role for Lgp2 in CD8(+) T cell survival: Lgp2 modulated the sensitivity of CD8(+) T cells to CD95 ligand-mediated cell death through the control of CD95 expression during WNV or lymphocytic choriomeningitis virus infection. Although the authors excluded a MDA5/Lgp2 interaction to be responsible for the observed CD95 modulation, it remained unclear if the effect in CD8(+) T cells occurs independently of RIG-I. In conclusion, Lgp2 appears to have a modulatory role in fine-tuning the innate immune response to viruses.

MDA5 -- biological role, target pathogens and ligand structure {#sec0020}
--------------------------------------------------------------

MDA5 recognizes long double stranded RNA and contributes to or even dominates the immune response to double strand (dsRNA) and positive strand RNA \[(+)ssRNA\] viruses ([Fig. 1](#fig0005){ref-type="fig"}) ([@bib0185], [@bib0200], [@bib0305], [@bib0380], [@bib0445], [@bib0450], [@bib0560], [@bib0575]). It is crucial for raising innate immune responses against picornaviruses, like Theiler\'s virus or encephalo-myocarditis virus (EMCV), enteroviruses, Saffold virus 3, human parechovirus 1, equine rhinitis A virus or the Caliciviridae family member Norovirus, which escape RIG-I recognition ([@bib0170], [@bib0200], [@bib0305], [@bib0445], [@bib0710]) ([Fig. 1](#fig0005){ref-type="fig"}). At first view, MDA5 appears to target virus types which are known to produce considerable amounts of dsRNA during their replication cycle, including (+)ssRNA, dsRNA or DNA viruses ([@bib0445], [@bib0450], [@bib0520], [@bib0560], [@bib0695], [@bib0735]). Correspondingly, two independent groups identified the double stranded replicative intermediates of (+)ssRNA enteroviruses as MDA5-stimulating RNA species ([@bib0170], [@bib0710]). A crystal with MDA5(ΔCARD) binding to dsRNA could be obtained ([@bib0750]).

However, the concept of dsRNA recognition by MDA5 seems incomplete. (−)ssRNA paramyxoviruses express the immune suppressive *V protein* which binds to and inhibits MDA5 directly, suggesting that also (−)ssRNA viruses (which were shown not to generate long double stranded RNA ([@bib0735])) produce MDA5 ligands ([@bib0020], [@bib0115], [@bib0410], [@bib0470]). In light of the above-mentioned studies, it appears unexpected that many double stranded RNA species do not activate MDA5. Thus far only one artificial, albeit enzymatically generated, MDA5-stimulating ligand (polyinosine-polycytidylic acid = poly I:C) has been described. It is composed of annealed strands of long (\>7000 nt) RNA polymers of inosins (polyI) and cytidines (polyC) ([@bib0200], [@bib0300], [@bib0305]). Most studies investigating the recognition of "long double stranded RNA" (dsRNA) in fact have used poly I:C. Of note, poly I:C is a very particular "dsRNA", as it was reported as the only co-polymer among many other artificial dsRNAs which was capable of inducing high amounts of type I IFN in mammalian cells ([@bib0175]). The absence of well-defined MDA5 ligands impairs systematic investigations of the MDA5--ligand interaction. Although the CTD of MDA5 binds blunt-ended dsRNA ([@bib0360], [@bib0750]), MDA5 is not activated by short dsRNA and no contribution of the CTD in discriminating MDA5 stimulating RNA has been demonstrated ([@bib0570]).

Even though poly I:C also binds and can stimulate RIG-I in certain cell lines and experimental settings *in vitro* ([@bib0300], [@bib0775]), it is important to note that poly I:C indeed fails to induce IFN-alpha when injected intravenously into MDA5-deficient mice or transfected *in vitro* into MDA5-deficient peritoneal macrophages, dendritic cells or MEFs ([@bib0200], [@bib0305]). By using poly I:C fragments of different sizes from RNase-III digestion, Kato and colleagues observed that MDA5 was only stimulated by long poly I:C fragments. An alternative interpretation of these results would be that RNase-III destroys certain secondary structures, which are required for recognition by MDA5. Pichlmair and colleagues concluded from testing of gel-fractionated RNAs of vaccina virus-infected cells that it was not the double-strandedness of RNA that accounted for MDA5 stimulating activity, but rather other higher order RNA structures in large RNA containing complexes ([@bib0520]). Luthra et al. discovered a mRNA fragment from the ss(−)RNA parainfluenza virus 5 (PIV5) that activated type-I IFN expression in a MDA5-dependent manner ([@bib0410]). Since type I IFN induction by this RNA required RNase L, the authors concluded that RNase L recognizes and processes viral mRNA into a MDA5 activating structure. Although a 432-nt-long region critical for MDA5 stimulation was identified, no specific features of a minimal recognition motif were found. The observation by Züst and colleagues that deficiency of the viral cap N~1~-2′O-methyltransferase in a type of (+)ssRNA corona virus (murine hepatitis virus; MHV) provoked recognition of this MHV by MDA5 and TLR7 ([@bib0800]) suggested a 5′end-dependent RNA recognition by MDA5. This finding would contrast the findings by Luthra et al., who expressed the MDA5 stimulatory mRNA from a promoter, which supports normal capping (including N~1~-2′O-methylation). However, binding assays documenting the interaction/non-interaction of the 5′end of viral transcripts with MDA5 were not performed. Indirect effects were therefore not excluded. Later studies on a N~1~-2′O-methyltransferase-lacking West Nile virus did not reveal a role of MDA5 in enhanced immune recognition of non-methylated cap structures ([@bib0670]), suggesting that N~1~-2′O-methylation does not generally impair MDA5 engagement.

RIG-I, ligand definition {#sec0025}
------------------------

Despite increasing amounts of high resolution crystal data on the RIG-I/ligand interaction, the ligand requirements for RIG-I stimulation are still controversial in the literature. By giving an overview of the history of the RIG-I ligand definition, the following section aims to help the reader to understand how different read-out systems and ligand preparation methods could lead to conflicting interpretation of data.

RNA modification {#sec0030}
----------------

When RIG-I was discovered as antiviral sensor by the Fujita group ([@bib0775]), the requirements of its RNA ligand were not explored. RIG-I was shown to bind to and to be stimulated by *poly I:C* when overexpressed in cell lines. At the same time, the group around John Rossi, while developing siRNAs against HIV, observed that all RNAs generated by phage-polymerase *in vitro* transcription ([@bib0315]) strongly induced type-I IFN in several human cell lines (HeLa, K562, HEK293, Jurkat, CEM). By contrast, synthetic siRNAs did not show any immune stimulatory effect in the same cell lines. DNA template-dependent RNA transcription occurs primer-independently from the 5′- to the 3′-end of RNA. For this reason, RNA transcripts of all known RNA polymerases, including phage polymerase, possess a triphosphate at the 5′end ([@bib0030]). By using phosphatase or RNase T1 (removes the 5′end pppG), Kim et al. could show that the 5′triphosphate was the crucial type-I IFN-inducing structural element of *in vitro* transcribed RNAs which was absent in synthetic siRNAs ([@bib0315]). This finding prompted us to analyze the IFN-alpha inducing capacity of *in vitro* transcribed 5′triphosphorylated RNA (pppRNA) in human blood cells ([@bib0240]). At this time, plasmacytoid dendritic cells (PDC) were presumed to be the principal type I IFN producing cells ([@bib0100], [@bib0630]). They express TLR7 and 9, and secrete large amounts of IFN-alpha upon TLR7 stimulation with single or double stranded RNA ([@bib0245]). Human monocytes express the RNA-sensing endosomal TLR8. However, TLR8 stimulation does not induce IFN-alpha secretion ([@bib0035]). Unexpectedly, pppRNA induced high levels of IFN-alpha not only in PDC but also in human monocytes. Therefore, pppRNA represented the first agent that induced IFN-alpha in human monocytes at comparable quantities to human PDC ([@bib0240]). Removal of the 5′triphosphate abrogated IFN-alpha induction by *in vitro* transcribed RNA in monocytes but not in PDC ([@bib0240]). Integration of nucleotides with modified bases (pseudouridine, 2-thio-uridine) or backbone modifications (2′O-methyl at uridines) abolished IFN-alpha induction by pppRNA both in PDC and monocytes. Using murine RIG-I/TLR7 deficient primary cells, RIG-I was identified to be crucial for pppRNA mediated IFN-alpha induction in myeloid immune cells, while TLR7 was essential for IFN-alpha induction in PDC ([@bib0240]). At the same time, Pichlmair and colleagues reported 5′phosphate-dependent type I IFN induction by Influenza virus vRNA, which contained no dsRNA detectable by a dsRNA specific antibody ([@bib0515]).

Sequence dependence of RIG-I recognition? {#sec0035}
-----------------------------------------

Saito and colleagues suggested that RIG-I detects (+)RNA viruses (HCV) in a sequence-dependent manner ([@bib0575]). They screened the HCV genome for RIG-I activating motifs by *in vitro* transcription of small domains of the HCV genome and analyzed the results for RIG-I binding and -activation. A transcript from an 100 nt U- or A-rich region 8000 nt downstream of the 5′end showed an exceptional RIG-I inducing activity. The presence of triphosphate at the 5′end was essential for RIG-I stimulation. Of note, a polyU sequence elicited a similar IFN response as the polyA sequence, which could be explained by a phenomenon to be discussed below. While developing phage-polymerase transcription-generated shRNA without RIG-I stimulating activity, Gondai and colleagues found that 5′end extension by more than one G abolished type I IFN induction ([@bib0205]). The results by Saito and Gondai suggested a sequence-dependent RNA recognition by RIG-I. However, later experiments with defined synthetic RIG-I ligands indicated that the work of both groups needs to be re-interpreted ([@bib0600], [@bib0610], [@bib0615]).

Synthetic dsRNA RIG-I ligands {#sec0040}
-----------------------------

Before 5′triphosphate was identified as the crucial RNA modification to induce RIG-I activation, Marques and colleagues observed that synthetic blunt ended dsRNA oligonucleotides can stimulate RIG-I ([Fig. 3](#fig0015){ref-type="fig"} ) ([@bib0440]). The read-out system used consisted of the glioblastoma cell line T98G, which was transfected with blunt ended or 3′overhang-possessing siRNAs. Type I IFN activity in these cells was monitored 48 or 72 h after transfection by western blot analysis of the type I IFN induced protein IFIT1 (p56), a very sensitive assay. In contrast to 3′overhangs possessing siRNA, blunt-ended siRNA induced substantial IFIT1 upregulation. Similar results were obtained with MRC-5 cells. SiRNA-mediated knockdown of RIG-I in T98G indicated involvement of RIG-I in the blunt-ended siRNA-induced type I IFN response. By contrast, HT1080 cells and HeLa cells did not respond to blunt-ended dsRNA, but exhibited IFIT1 induction after transfection of *in vitro* transcribed RNA. The response to blunt dsRNA could be restored in HT1080 cells by priming with type I IFN. According to the described results, the RIG-I stimulation motif was defined as double blunt-ended dsRNA longer than 23 bp. Single blunt-ended siRNAs were less active. 5′overhangs were reported to permit detectable activity after 72 h of stimulation while 3′overhangs abolished activity ([Fig. 3](#fig0015){ref-type="fig"}) ([@bib0440]).Fig. 3Synthetic RNA ligands tested for RIG-I activation. Upper strands are in 5′--3′ direction, lower strands in 3′--5′ direction.

Further studies analyzed the physical interaction of recombinant full-length RIG-I or CARD- or CTD deficient mutants with synthetic blunt-ended dsRNA in comparison to *in vitro* transcribed single stranded pppRNA (*ivt*ppp-ssRNA) ([@bib0130]). While full length RIG-I was highly activated by *ivt*ppp-ssRNA, synthetic non-phosphorylated dsRNA induced RIG-I to a much weaker degree. Unexpectedly, for RIG-I lacking the CARD domain, dsRNA and *ivt*pppRNA showed comparable ATPase activity. By contrast, interaction studies using fluorescence anisotropy with recombinant RIG-I protein or the recombinant RIG-I CTD domain confirmed the requirement of the 5′triphosphate for substantial interaction with full-length RIG-I ([@bib0130]). Takahasi and colleagues reported a RIG-I-dependent type I IFN response to synthetic 5′-monophosphorylated and 3′-monophosphorylated dsRNA oligonucleotides in an IFN-beta-primed murine cell line and in IFN-beta-treated mouse embryonic fibroblasts (MEF). The type I IFN response was monitored by IFNbeta promoter reporter assays and IRF-3 dimerization ([Fig. 3](#fig0015){ref-type="fig"}) ([@bib0680]). In this setting non-modified synthetic dsRNA did not induce type I IFN ([@bib0680]). In accordance with earlier studies ([@bib0440]), 3′-overhangs at the 5′-monophosphorylated end abrogated the type I IFN response, while 5′overhangs were not tested ([Fig. 3](#fig0015){ref-type="fig"}) ([@bib0680]). By contrast, 2 nt 3′overhangs in 3′monophosphorylated dsRNA induced a type-I IFN response (no other end structures, *e.g.* blunt, 5′overhang, were analyzed). Unexpectedly, the authors found that monophosphorylation did not enforce RIG-I binding of dsRNA but increased RNA stability in the cells, suggesting that increased RNA stability is responsible for the particular RIG-I stimulating activity ([@bib0680]).

Synthetic triphosphorylated dsRNA ligands {#sec0045}
-----------------------------------------

Since the 5′triphosphorylated end sequence of RNAs generated by phage polymerase is restricted to a conserved consensus starting nucleotide G (or A followed by G), *in vitro* transcription is not applicable for screening of sequence variations at the 5′end of triphosphorylated oligonucleotides. Therefore, our group established a method to generate synthetic triphosphorylated RNAs ([@bib0610]) which is based on the standard cyclotriphosphate protocol of triphosphate synthesis ([@bib0395]). Unexpectedly, synthetic single stranded triphosphorylated RNA (ppp-ssRNA) did not induce type-I IFN in human monocytes, while the "same" RNA sequence generated by *in vitro* transcription (*ivt*ppp-ssRNA) was a strong type-I IFN inducer. Sequencing of products from the *ivt*ppp-ssRNA transcription mix revealed the presence of complementary sequences and double stranded hairpin species, which were obviously generated by template-dependent RNA transcription, a side activity of phage polymerase that had been reported earlier ([@bib0090], [@bib0705]). Transcription reaction conditions that did not allow synthesis of complementary RNA abrogated RIG-I activation by *ivt*ppp-ssRNA completely, suggesting that RIG-I was not stimulated by the intended ssRNA transcript but rather by side products ([@bib0610]). Hence, hybridization of a complementary ssRNA strand reconstituted RIG-I stimulation by synthetic ppp-ssRNA. Optimal RIG-I agonists appeared to be blunt ended, while 2 nt 3′overhangs at the 5′triphosphate end impaired RIG-I activation by more than 70% ([Fig. 3](#fig0015){ref-type="fig"}). 5′overhangs of the triphosphorylated end were not tolerated, thus demonstrating that base pairing of the nucleotide carrying the 5′triphosphate is essential for RIG-I activation. The non-phosphorylated end structure had no substantial impact on RIG-I stimulation, as long as the dsRNA encompassed at least 19 base pairs. Small (3 nt) bulge loops in the center of the sequence were tolerated. All four nucleotides constituted active triphosphorylated 5′ends of the RIG-I ligand. Activity of pppA, pppG and pppU differed only slightly (A = G \> U), whereas pppC induced around 50% less type I IFN. Of note, this sequence-dependency that was observed is based on only one dsRNA sequence (**[N]{.ul}**ACACACACACACACACACACUUU), and remains to be verified in another sequence context. According to the public databases, no genomic viral RNAs (vRNA) start with pppC but most start vRNA with pppA.

At the same time, by testing synthetic ppp-ssRNA, Schmidt and colleagues ([Fig. 3](#fig0015){ref-type="fig"}) confirmed the importance of dsRNA ([@bib0615]). In disparity with our results, they observed that RIG-I tolerates a 1 nt 5′overhang at the ppp bearing end for one tested sequences. By using phage polymerase-generated hairpin pppRNA structures with intended 5′ppp overhangs, they concluded that longer (\>1 nt) 5′overhangs in hairpin pppRNAs are tolerated. However, this interpretation may be misleading since *in vitro* transcribed pppRNA hairpins with overhangs (accurate transcription/identity was not analyzed by mass spectrometry) are likely to be contaminated with completely double stranded material ([@bib0090], [@bib0705]). In our experience, one-time size fractionation of hairpin RNA is not sufficient to exclude contamination of transcripts with small size differences completely. On the other hand, it has to be considered that hairpins are in equilibrium with their self-complementary duplex ([@bib0480]), which is supposed to be a more active ligand than the monomeric hairpin ([@bib0065]). Thus, small contaminations can cause substantial effects. Schmidt et al. reported that a double stranded region of minimum 10 bp length is sufficient for RIG-I activation. In their test they included three different sizes of ppp-dsRNA (15, 10 and 5 bp, blunt at the ppp-end). Curiously, a 10mer ppp-dsRNA induced a stronger type-I IFN response than a 15mer. As a direct comparison of the full 19mer duplex pppRNA to the 15mer and 10mer is missing, the interpretation of the result remains difficult ([@bib0615]). Altogether, it remains unclear whether just any 10mer duplex ppp-dsRNA sequence can activate RIG-I. It has to be considered that the possibility of non-canonical base pairings of RNA (*e.g.* G-U wobbles) provides manifold alternatives to form double stranded structures, all of which have to be kept in mind when claiming that RNA structures are single stranded.

To date only a small number of synthetic ppp-dsRNA sequences have been analyzed (seven in our work ([@bib0610]), one in the work of [@bib0615]). It is possible that a stabilizing nucleotide sequence next to the 5′ppp end enables a tolerance of 1 nt 5′-ppp-overhangs. Using highly purified *in vitro* transcribed pppRNA from arenavirus sequences [@bib0435] confirmed the requirement of a base paired 5′-ppp end of dsRNA for RIG-I activation and suggested that some arenaviruses and bunyaviruses use a *prime and realign* mechanism for genome synthesis, leading to 5′overhangs in order to evade RIG-I recognition ([@bib0435]).

The need of a base-paired 5′-ppp end of dsRNA was also validated by the assembly of the RIG-I ligand within the RIG-I CTD ppp-dsRNA binding cleft ([@bib0390], [@bib0725]). 5′ppp-terminal base pairing supports an essential stacking interaction with a conserved phenylalanine residue in the RNA binding cleft of the CTD. In addition, in contrast to a single base pair, which allows free rotation of the following sequence, the double strand assembly stabilizes the helix in a fixed optimum position for interaction of the adjoining phosphodiester backbone with the CTD and the helicase domain ([Fig. 4](#fig0020){ref-type="fig"} ) ([@bib0325]). In disparity to previous studies using type-I IFN-primed murine cells as a read-out ([@bib0680]), no considerable type I IFN induction was observed after 24 h when human monocytes were transfected with 5′monophosphorylated dsRNAs ([@bib0610], [@bib0615]). Of note, Schmidt and colleagues tested the same sequences, which were previously reported to induce type I IFN in type I IFN-primed MEFs ([@bib0615], [@bib0680]). By contrast, in both studies monophosphorylated and non-phosphorylated dsRNA induced a substantial ATPase activity of RIG-I protein at higher RNA doses ([@bib0610], [@bib0615]). This indicates that RIG-I activation observed by [@bib0440] and [@bib0680] could occur because of relatively high local RNA concentrations in the cytosol. Further factors, sensitizing the readout and leading to contradictory results are most likely due to the use of highly RIG-I responsive cell lines (T98G) or murine cells combined with long incubation times (48--72 h ([@bib0440])), pre-activation by incubation with type I IFN ([@bib0440], [@bib0680]) and sensitive detection methods (IFIT1 western blot, IFN-beta reporter assay, IRF-3 dimerization ([@bib0440], [@bib0680])). Using gel shift experiments with radioactive labeled ligand, Vela et al. could calculate that the triphosphate moiety of dsRNA enhanced binding to the CTD 127 fold ([@bib0715]). The crystallization of RIG-I CTD with 5′OH-dsRNA by Lu and colleagues revealed that binding of 5′OH-dsRNA in the CTD RNA binding cleft is possible ([@bib0385]). Although the assembly for 5′OH-dsRNA resembles that of 5′ppp-dsRNA, the crystal data reveal that 5′OH-dsRNA binds in a different angle, and with other amino acid positions. Habjan and colleagues observed that Crimean-Congo hemorrhagic fever virus (CCHTV), Hantaan virus (HTNV), and Borna disease virus (BDV) can prevent RIG-I mediated detection of their genomes by a *prime and realign* mechanism and cleavage of the 5′ terminal base of their genomic RNA leaving monophosphorylated 5′ends ([@bib0215]) ([Fig. 1](#fig0005){ref-type="fig"}). In contrast to 5′ppp ended genomic RNA, the genomic RNAs of CCHTV, HTNV or BDV with 5′monophosphorylated ends (pRNA) failed to bind or to activate RIG-I when transfected into HEK293 cells. This laborious procedure of (−)ssRNA viruses to generate 5′monophosphorylated genomes to prevent RIG-I recognition does not support the concept that pRNA is a preferred target structure for RIG-I during viral infection.Fig. 4RIG-I CTD interaction with blunt ppp-dsRNA. K858, K851, K849, H847, K861, K888 constitute a basic binding cleft which binds 5′triphosphate. K907 interacts with backbone phosphates. H830 and C829 bind to the 2′OH groups of the first two nucleotides of the ppp-dsRNA.

The occurrence of aberrant dsRNA during phage polymerase *in vitro* transcription questions the data interpretation from earlier studies, which intended to identify RIG-I recognition sequences based on experiments with *in vitro* transcribed RNA. The observations of Gondai and colleagues can easily be explained by the non-acceptance of 5′ppp-overhang structures ([@bib0205]): shRNAs consisting of a RNA hairpin with base paired 5′ppp-ends and a UU 3′-overhang induced RIG-I. Extra Gs at the 5′-ppp end generated single stranded or mismatched 5′ppp ends (5′ppp-overhang), which fail to stimulate RIG-I.

The finding that pppRNA composed of polyA or poly U stretches are equally potent RIG-I inducers can be explained by the possibility that both complementary RNA species are generated in the phage-polymerase transcription reaction that was intended to produce only one ssRNA species and form a duplex ([@bib0575]). By using the same template as used by Saito and colleagues for phage polymerase-mediated generation of the RIG-I stimulating "poly A" rich sequence (which in fact is composed of starting Gs and A), Schmidt and colleagues did not receive any RIG-I stimulating activity when UTP or CTP were omitted in the transcription mix ([@bib0575], [@bib0615]). By contrast, addition of UTP and CTP yielded RIG-I-activating RNA as reported ([@bib0575], [@bib0615]), suggesting that a double stranded polyA/polyU rich sequence constitutes the RIG-I activating agent. Potent RIG-I stimulation by this structure can be explained by the fact that poly A and poly U represent sequences that are not able to form stable secondary structures. Absence of secondary structures facilitates the hybridization of complementary RNAs at low temperature to uniform dsRNA structures in comparison to mixed high melting G/C containing sequences. It is important to note that subgenomic (single stranded) RNAs of HCV were reported to have 5′monophosphorylated ends ([@bib0675]). Since RIG-I activation by polyU strictly depended on the presence of 5′triphosphate ([@bib0575]), triphosphate-dependent RIG-I stimulation *in vivo* can happen by recognition of replicative pppRNA intermediates, which are generated during replication and are, in fact, double stranded ([@bib0695]). In summary, for RIG-I recognition structural features appear to be more important than the sequences of candidate ppp-dsRNA.

Mechanisms of RNA recognition by RIG-I like receptors -- insights from structural data {#sec0050}
--------------------------------------------------------------------------------------

RIG-I possesses two RNA binding domains (DECH domain and CTD). Pioneering studies involving crystal structure analysis or NMR from the Hopfner and the Fuijita lab identified a basic binding cleft within the CTD of RIG-I (amino acids 802--925) as the crucial pppRNA binding structure that determines ligand specificity ([@bib0130], [@bib0325], [@bib0680]). As described above, ppp-dsRNA bound to the CTD displaces autoinactivated CARDs from binding to the helicase domain, leading to liberation and activation of CARDs and downstream events that culminate in the induction of type I IFN \[reviewed in [@bib0325]\]. Using synthetic or highly purified *in vitro* transcribed triphosphorylated RNA led to the resolution of the crystal structure of the RIG-I CTD bound to 12mer ppp-dsRNA palindromic sequences ([@bib0390], [@bib0725]). The crystal structures revealed an RNA binding basic binding cleft with highly conserved amino acids involved in binding of the 5′terminal base pair, the triphosphate structure itself, and backbone phosphate ([Fig. 4](#fig0020){ref-type="fig"}). K849 and K851 (amino acid numbers in the text always refer to human RIG-I sequence) are in proximity to the gamma phosphate of the triphosphate. However, conservative K849 and K851 mutations to alanine (A) impaired RIG-I activation only at very low ligand concentrations ([@bib0725]), suggesting a minor role of this interaction in RIG-I mediated recognition of viral RNA. K858, H847 and K861 were identified to interact with the beta phosphate of the triphosphate. Substitution of K861 to A, which is also in contact with alpha phosphate, or double substitution of H847 and K858 to A, abrogated RIG-I activation by ppp-dsRNA. Likewise substitution of K888, being in contact with the alpha phosphate group, inhibited recognition of ppp-dsRNA by RIG-I. The side chain of K907 is in contact with either the backbone phosphate between N2 and N3 ([@bib0725]) or N3 and N4 ([@bib0390]). Since substitution of K907 to A abolishes RIG-I activation completely ([@bib0725]) this backbone phosphate interaction appears to be crucial for the detection of the ribose backbone of a dsRNA structure. The contact of K907 to the phosphate between N2 and N3 ([@bib0725]) or N3 and N4, as reported in another study ([@bib0390]), could either depend on the incorporated oligonucleotide sequence (pppGACGCUAGCGUC ([@bib0725]) or pppGGCGCGCGCGCGCC ([@bib0390])) or the crystal packaging. In summary, both studies exhibited very similar pppRNA/CTD structures.

Of note, the amino acids mediating RNA ligand binding (H847, K858, K861, K888 and K907) are 100% conserved in the RIG-I sequences of vertebrates, highlighting the importance of these positions for RIG-I-mediated RNA-virus recognition. F853 is also essential for RIG-I activation ([@bib0725]). It conducts the crucial stacking interaction with the 5′terminal base pair ([Fig. 4](#fig0020){ref-type="fig"}), mediating the RIG-I selectivity for base paired triphosphorylated RNA. The stacking interaction is stabilized by base pairing of N~1~. In addition, base pairing of the interacting base pair prevents free rotation of the following RNA strand and in this way can assure appropriate assembly in the CTD structure ([@bib0325]), another argument for the strict necessity of a base pairing at the triphosphate-bearing end of dsRNA to stimulate RIG-I. As suggested by the comparison of RIG-I CTD of different vertebrate species, F853 can only be substituted by the functionally related tyrosine (Y). H830 and C829 mediate possibly important backbone interactions with the 2′OH groups of the ribose of N~1~ and N~2~, suggesting a strict discrimination of RNA *versus* DNA at those positions.

The conclusion by Lu and colleagues that RIG-I can bind and simultaneously be stimulated by single-stranded pppRNA has to be questioned, since *in vitro* transcribed RNA (which usually contains ppp-dsRNA species) was used for stimulation of cells ([@bib0390]). Although the RIG-I CTD appears to interact only with the ppp-bearing RNA strand, helix formation should be still crucial for appropriate interaction of the RNA with the contacting amino acid residues of H853, K907, H830 and C829. Marq and colleagues found that non-stimulatory ppp-dsRNA (ppp-dsRNA with 5′ppp-overhang) can bind RIG-I with comparable affinity as active ligands (complete ppp-dsRNA) indicating the possibility of stimulatory ("productive") and non-stimulatory ("non-productive") ligand binding modes to RIG-I ([@bib0430]). These data suggest that *binding* to RIG-I is essential but not sufficient for *activation* of RIG-I. Two independent studies found that the presence of CARDs strongly reduce the tolerance for binding of OH-dsRNA, thus represent a considerable contribution to the selective recognition 5′triphosphorylated RNA ([@bib0130], [@bib0715]). Additionally, based on energetic parameters of the RIG-I dsRNA interaction, Vela et al. suggested that a relatively low affinity of full-length RIG-I for dsRNA and, therefore, enhanced target specificity is mediated through antagonistic domain binding between helicase and CTD ([@bib0715]).

The CTD of the RIG-I inhibiting helicase Lgp2 is closely related to the RIG-I CTD ([@bib0365], [@bib0525]). Similar to RIG-I, Lgp2 was reported to preferentially bind to blunt ended dsRNA ([@bib0365], [@bib0475], [@bib0525]), albeit in a 5′triphosphate independent manner ([@bib0525]). Amino acids mediating the interaction with the 5′terminal base pair and the ribose backbone (H830^RIG-I^, F853^RIG-I^, K888 ^RIG-I^, K907^RIG-I^  = H576^Lgp2^, W604^Lgp2^, K634^Lgp2^, K651^Lgp2^) are conserved or at least functionally related between the RIG-I and the Lgp2 CTD, while triphosphate-interacting amino acids (H847, K849, K858 and K861) are missing in the Lgp2 CTD. H576^Lgp2^, W604^Lgp2^ K634^Lgp2^ and K651^Lgp2^were found to be involved in dsRNA binding of the Lgp2 CTD ([@bib0365], [@bib0525]). Conversely, the binding mode of OH-dsRNA to Lgp2 differed considerably from the binding mode of ppp-dsRNA. Confusingly, mutation of the amino acids in the Lgp2 CTD corresponding to K888^RIG-I^ (K634^Lgp2^  → E) and K907^RIG-I^ (K651^Lgp2^  → E) led to loss of RNA binding but did *not* impair Lgp2-mediated inhibition of RIG-I activation, suggesting a ligand-independent RIG-I inhibiting mechanism by Lgp2 ([@bib0365]).

Triphosphate independent recognition of long double stranded RNA by RIG-I {#sec0055}
-------------------------------------------------------------------------

The RIG-I ligand requirements for short dsRNA described above is in contrast to the initial finding that RIG-I can be activated by poly I:C ([@bib0775]), a dsRNA polymer with monophosphates at the 5′ end ([@bib0210]). In order to characterize ligand structure motifs differentiating RIG-I and MDA5 recognition, Kato and colleagues fractionated RNase III-digested poly I:C (resulting in 5′monophosphates and 2 nt 3′overhangs). While 7 kb poly I:C fragments (high molecular weight) were preferentially detected by MDA5, fractions equal to 300 bp or smaller were exclusively recognized by RIG-I ([@bib0300]). [@bib0065] found an inverse correlation: in their experiments, dsRNAs of different length (40--1600 bp) were assessed for RIG-I stimulating activity in RIG-I transgenic Huh7.5 cells. They observed that molecular weight of ppp-dsRNA positively correlated with RIG-I activation. Of note, Binder et al. compared RIG-I activation at relatively low concentration with constant molarity while Kato et al. analyzed RIG-I activity transfecting high concentrations (1 μg/ml) at constant mass concentration ([@bib0065], [@bib0300]). Binder et al. could reproduce the results of Kato et al. when transfecting high amounts (0.1 pmol/well) of RNA. Nevertheless, both studies observed 5′triphosphate independent activation of RIG-I by very long (≥100 bp) dsRNA. Length-dependent, 5′end-independent RIG-I activation cannot be explained with the current model of CTD-mediated recognition. Binder et al. proposed an alternative CTD-independent recognition mechanism (cooperative multimerization of RIG-I) in which binding of one RIG-I molecule facilitates the binding of a second, *etc.* ([@bib0065]). In this case, binding can only occur in a helicase-dependent manner and would enable displacement of the CARDs, leading to initiation of the signaling cascade. Based on multi-angle light scattering and size-exclusion chromatography-coupled small-angle X-ray scattering of RIG-I/29mer dsRNA complexes, Beckham e al. suggested that binding of a first RIG-I molecule changes the RNA structure, thus constructively influencing the binding of a second RIG-I molecule ([@bib0050]).

However, if RIG-I can be activated by long dsRNA in a 5′end independent manner, the question still remains why long double-stranded replicative RNA intermediates purified from (+)ssRNA picornaviruses, are not recognized by RIG-I ([@bib0170]).

RNase cleavage products--ligands for RIG-I and MDA5? {#sec0060}
----------------------------------------------------

[@bib0420] observed that activated antiviral endoribonuclease RNase L generates small RNA cleavage products from self-RNA that induce type I IFN production ([@bib0420]). In this study both, MDA5 and RIG-I were reported to contribute to recognition of small (\<200 nt) RNase L cleavage products of total cellular RNA. Importantly, the type I IFN-induced RNase L digests single-stranded RNA into RNA products with 5′-OH and 3′-monophosphate groups. By reverse sequencing in a follow-up study, Malathi et al. discovered HCV genome sequence-derived RNase-L cleavage products that bind to RIG-I ([@bib0425]). One of 15 RIG-I binding RNA sequences was able to significantly activate RIG-I in a 3′monophosphate-dependent but 5′triphosphate-independent manner. The putative structure of RIG-I activating sequence included long (\>20 bp) dsRNA regions but also long (\>5 nt) single stranded 5′ and 3′ ends. As the sequence was generated by *in vitro* transcription and not validated by mass spectrometry, it remains unclear whether the intended structure or co-purified side products from *in vitro* transcription are responsible for RIG-I stimulation. Nevertheless, the study indicates that special RNA structures exist, which can stimulate RIG-I in a 3′monophosphate-dependent manner and that these kinds of structures can be generated by RNase L cleavage of RNA virus genomes. Of note, 3′monophosphate-dependent RIG-I stimulation was also reported earlier by the Fujita group ([@bib0680]).

RNA polymerase III transcripts {#sec0065}
------------------------------

At the same time, the Akira lab and the Medzhitov lab reported a TLR9-independent type I IFN induction when dsDNA was transfected into the cytosol of cells ([@bib0265], [@bib0640]). Knock-down of MAVS in 293T cells significantly reduced dsDNA-induced type I IFN, suggesting a MAVS-dependent pathway of dsDNA recognition in these cells ([@bib0265]). Unexpectedly, MAVS-deficient murine cells still responded to dsDNA ([@bib0660]). Importantly, the Akira lab used a special type of dsDNA, the heteropolymer dAdT (a polymer of the alternating sequence AT). Cheng et al. observed that human cell lines (Huh7, HEK293) secrete type I IFN in a MAVS and RIG-I-dependent manner after transfection of dAdT but not plasmid DNA ([@bib0105]). The dAdT enigma was later solved by two independent groups ([@bib0010], [@bib0120]): Ablasser et al. and Chiu et al. discovered that dAdT functions as a template for the endogenous RNA polymerase III, which generates 5′triphosphorylated AU-polymers in the cytosol ([@bib0120]). AT-rich DNA is in two ways a special kind of DNA: first, RNA polymerase III prefers transcription of AT-rich sequences; second, the resulting pppAU-polymers are self-complementary and can easily anneal to ppp-dsRNA. They therefore represent excellent RIG-I target structures ([@bib0010]). Thus, it has to be kept in mind that "RIG-I stimulating DNA" needs to provide two features: first, the DNA needs to be able to serve as a template for RNA polymerase III, second, the transcript has to form an appropriate RIG-I ligand structure (base paired 5′ppp end + dsRNA \> 19 bp). Most natural dsDNA structures do not provide both features. Some DNA virus (*e.g.* Epstein Barr virus and Adenovirus) encode for small RNAs (*EBER* and *VAI*) under the control of a polymerase III-driven promoter; these were observed to stimulate RIG-I ([@bib0010], [@bib0460], [@bib0580]).

Unlike murine cells and human monocytic cells, most human cell lines are not stimulated by dsDNAs (*e.g.* plasmid DNA or PCR products) other than dAdT. This indicates the absence of a receptor in the cytosol, which can recognize DNA directly in those cell lines ([@bib0010], [@bib0105]). In those cells, the RNA Polymerase III/RIG-I pathway constitutes the only alternative to detect cytosolic dsDNA. Since some DNA viruses and facultative intracellular bacteria induced a MAVS or RIG-I-dependent type I IFN response in non-immune cells, it was suggested that in these cells the innate immune response to intracellular dsDNA-containing pathogens can occur *via* stimulation of RIG-I by pathogen-DNA templated polymerase III transcripts ([@bib0010], [@bib0120]). As will be summarized in the next section, intracellular bacteria were actually shown to release RNA into the cytosol of cells, which is then recognized by RIG-I ([@bib0005], [@bib0220]).

RIG-I senses pppRNA from bacteria {#sec0070}
---------------------------------

In general, all RNA polymerase-dependent transcribed RNAs initially possess a 5′triphosphorylated start nucleotide. Posttranscriptional 5′processing or modification such as capping are key features of mRNA translation regulation in eucaryotes. In contrast to eucaryotes, one third of *Escherichia coli* (bacterial) mRNA remains 5′triphosphorylated ([@bib0060]). Regulation of the 5′phosphorylation status of bacterial mRNA, which determines mRNA decay ([@bib0095]), occurs *via* the pyrophosphatase RppH ([@bib0140]). The 5′triphosphate moiety prevents degradation of bacterial mRNA by RNase-E ([@bib0095]). Importantly, pyrophosphatase RppH preferentially targets single-stranded triphosphorylated 5′nucleotides as a substrate, consequently leaving 5′triphosphorylated dsRNA ([@bib0140]). This conclusion is supported by the finding that 5′-terminal stem-loops prolong the lifetime of bacterial RNAs ([@bib0160], [@bib0415]). Thus, base-paired 5′triphosphorylated RNAs (ppp-dsRNA), which are an excellent target structure for RIG-I, appear to represent a characteristic molecular pattern (MAMP) for bacteria.

In a siRNA-based approach, Opitz et al. observed that *Legionella pneumophilae*, a facultative intracellular gram-negative bacterium with type IV secretion system, raised a MAVS-dependent but RIG-I- or MDA5-independent type-I IFN response in a human endothelial cell line (A549) ([@bib0495]). The involvement of MAVS in the *L. pneumophilae* induced immune response was later affirmed in experiments with MAVS- and MDA5-deficient, anti-RIG-I shRNA-expressing bone marrow-derived macrophage cell lines ([@bib0465]). In contrast to findings by [@bib0495], contribution of MDA5 and RIG-I to the type I IFN response was reported ([@bib0465]). While knock-down of RIG-I substantially reduced the response to transfected purified bacterial RNA, it remained an open question whether *Legionella*-derived RNA actually gains access to the cytosol of the host cell during infection. As MDA5 appeared to not directly sense bacterial RNA, the authors speculated about an indirect mechanism leading to activation of RIG-I and MDA5. Importantly, DNA from *L. pneumophilae* did not induce type I IFN in HEK293 cells, thus excluding RIG-I-mediated recognition of RNA polymerase-III transcripts in the host cell, as previously suggested ([@bib0120], [@bib0465]). Recognition of bacterial RNA by RIG-I was also observed for the bacterium *Helicobacter pylori* ([@bib0540]). Abdullah et al. discovered that the facultative intracellular bacterium *Listeria monocytogenes* actively secrete small RNAs *via* its SecA2 secretion system resulting in strong RIG-I activating activity ([@bib0005]). Recently, we visualized translocation of bacterial RNA from *L. monocytogenes* into the cytosol of several human cell lines ([@bib0220]). Previously, *L. monocytogenes* was reported to induce type I IFN exclusively *via* the STING pathway, an adaptor/receptor sensing second messenger molecules or cyclic nucleic acids either directly secreted by *L. monocytogenes* (cyclic di-AMP) or generated downstream of cytosolic DNA recognition (GMP-AMP) in mammalian cells ([@bib0270], [@bib0590], [@bib0655], [@bib0745], [@bib0755], [@bib0790]). We found that the *L. monocytogenes*-triggered type I IFN response is dependent on RIG-I recognition when the STING pathway is not present in cells, this being the case in tested non-immune cells ([@bib0220]). In immune cells such as the human cell line THP-1 the STING-dependent recognition pathway dominates the immune response to *L. monocytogenes* while RIG-I appears to not play any role in recognition ([@bib0220]). In this respect, data for murine cells are conflicting: while some studies excluded involvement of RIG-I/MAVS in *L. monocytogenes* recognition in macrophages ([@bib0635], [@bib0660]) another study observed a substantial contribution of the RIG-I pathway ([@bib0005]). Culturing conditions of bacteria and murine cells may influence the amount of transferred bacterial pppRNA and the balance between RIG-I and the STING pathway in murine macrophages, thus leading to controversial findings. Interestingly, Li et al. found that RNA of commensal bacteria is recognized in a MAVS-dependent manner and that MAVS in cells of non-hematopoietic origin plays a dominant role in preventing DSS-induced colitis ([@bib0370]), supporting that RIG-I-inducing bacterial RNA indeed has access to non-immune cells *in vivo* and mediates important effects. This finding explained the observation by Wang et al. that RIG-I deficient mice easily develop colitis ([@bib0730]).

Considering the fact that mice with a defect in the type I IFN pathway exhibit a strong resistance to *Listeria*-induced pathogenesis, it remains to be determined if the observed RIG-I-dependent recognition of bacterial RNA contributes more to the pathogenicity or to the clearance of *Listeria* ([@bib0025], [@bib0490]).

Detection of viral RNA -- which structure stimulates RIG-I? {#sec0075}
-----------------------------------------------------------

### (+)ssRNA/dsRNA viruses {#sec0105}

In addition to dsRNA viruses positive single-strand RNA \[(+)ssRNA\] viruses also generate cytosolic dsRNA species, such as replicative dsRNA intermediates, during their replication ([@bib0170], [@bib0695], [@bib0710], [@bib0735]). Together with 5′triphosphate, such RNA species represent ideal RIG-I target structures.

Since picornaviruses were shown not to activate RIG-I during infection ([@bib0200], [@bib0305]) it was presumed that picornaviruses (and caliciviruses) ([Fig. 1](#fig0005){ref-type="fig"}) are able to escape RIG-I recognition because instead of a 5′triphosphate their RNA genomes possess a peptide (Vpg) linked *via* a tyrosine residue to 5′monophosphate ([@bib0255], [@bib0350], [@bib0555]). In line with these findings, Feng et al. observed that purified picorna virus RNA stimulated MDA5 but not RIG-I ([@bib0170]). Additionally and rather unexpectedly, picornaviruses were observed to degrade RIG-I during infection. The apparent need to degrade RIG-I indicates the occurrence of some RIG-I stimulating activity, the identity of which has not been clarified so far ([@bib0040], [@bib0500]).

### (−)ssRNA viruses {#sec0085}

RIG-I dominates the immune response to many (−)ssRNA viruses ([@bib0085], [@bib0215], [@bib0240], [@bib0295], [@bib0305], [@bib0380], [@bib0530], [@bib0770]). However, three out of four so far analyzed (−)ssRNA viruses were described *not* to generate double-stranded RNA species during infection (no dsRNA: influenza; Sendai virus, SeV; La Crosse Virus, LACV; dsRNA detectable: New Castle disease virus, NDV) ([@bib0515], [@bib0685], [@bib0735]). This finding may seem conflicting at first, but can be explained by the fact that the dsRNA-visualizing antibody used in these studies is only able to bind dsRNA longer than 40 bases ([@bib0075]) but RIG-I can recognize ppp-dsRNA ≥ 19 bp.

In general, the complementary 5′ and 3′ terminal sequences of all (−)ssRNA viruses genomes bear the potential to hybridize to so-called dsRNA *panhandle* structures with blunt ended 5′triphosphorylated ends ([Fig. 1](#fig0005){ref-type="fig"}, left bottom). A certain degree of self-complementarity cannot be avoided by (−)ssRNA viruses since the same viral polymerase which recognizes its start sequence needs to start mRNA transcription or replication from the (−)ssRNA or (+)ssRNA intermediates. For Bunyaviridae, including LACV, it was validated by psoralen-crosslinking and electron microscopy that the 5′- and 3′-ends of the viral genome indeed constituted a panhandle structure *in vivo* ([@bib0235], [@bib0545]). The LACV panhandle consists of a blunt-ended 24--27 bp dsRNA stretch with only a few mismatched nucleotides ([@bib0545]), thereby achieving almost all RIG-I ligand requirements ([@bib0610]) without being detected by the 40pb RNA-specific antibody. Marq et al. suggested that for this reason some arenaviruses and bunyaviruses circumvent RIG-I recognition by conducting a *prime and realign* mechanism which enables generation of 5′overhangs in their genomes ([@bib0435]). As mentioned above, Habjan et al. identified viruses (Bornaviridae, Bunyaviridae), which escape RIG-I recognition by combination of a *prime and realign* mechanism to 5′terminal cleavage, leaving a 5′monophosphorylated end ([Fig. 1](#fig0005){ref-type="fig"}, "RLR escape").

By using replication and translation blocking agents, applying enzymatic probing and visualization by superresolution microscopy, Weber et al. confirmed that RIG-I indeed recognizes viral capsids of LACV upon entry into the cell by binding to the panhandle structure ([@bib0740]).

Similar to LACV, influenza virus genomic pppRNA (comprising 8 segments with conserved 5′ends) forms triphosphorylated, panhandle structures, albeit with quite short double stranded stretches (about 15 bp), including mismatches/bulge loop structures ([@bib0145], [@bib0260]). This *panhandle* structure represents the site of RNA transcription-initiation for the viral RNA polymerase complex in the nucleus of the host cell ([@bib0535]). Dauber et al. observed that the Influenza panhandle is accessible for the antiviral double-stranded RNA-dependent protein kinase (PKR) after export from the nucleus into the cytosol of the host cell ([@bib0135]). Since PKR and RIG-I recognize comparable dsRNA structures--short triphosphorylated dsRNA ([@bib0485], [@bib0610]), it is likely that RIG-I also has access to the Influenza panhandle structure in the cytosol. If the Influenza panhandle is indeed sufficient to activate RIG-I still remains to be verified using well-defined RIG-I ligands. Rehwinkel and colleagues generated mutated Influenza RNA polymerases which either selectively produce viral mRNA or replicative genomic RNA ([@bib0550]). Using this tool, they confirmed that RIG-I activation occurs exclusively by the genomic RNA and not mRNA of Influenza ([@bib0550]). Additionally, analysis of RIG-I-bound viral RNA from Influenza infected cells revealed that only 5′triphosphorylated viral genomic RNA co-precipitated with RIG-I.

In contrast to LACV and Influenza, viral particles of Sendai Virus (SeV) and Measles Virus (MeV) which belong to the group of *Mononegavirales* contain predominantly linear nucleocapsids because encapsidation with structural proteins prevents formation of double stranded or panhandle structures ([@bib0055], [@bib0195], [@bib0375]). But SeV and VSV were found to produce defective interfering (DI) viral genomes during replication ([@bib0320], [@bib0345], [@bib0510]). Three kinds of DI genomes were identified: DI genomes with internal deletions, 5′promoter duplications with completely complementary 5′--3′ ends, and hairpin DI genomes "snap back", consisting of a dsRNA hairpin of 100--1000 bp ([Fig. 1](#fig0005){ref-type="fig"}). "Panhandle" and "snap back" DI RNAs should result in excellent RIG-I ligands. Indeed, Strahle et al. could correlate Sendai virus-induced RIG-I activation with the occurrence of snap back DI genomes (DI-H4) which are generated during infection without encapsidation and thus are able to form panhandle structures in infected cells ([@bib0645], [@bib0650]). In concordance with these data, by applying a deep sequencing approach after purification of RNA attached to RIG-I from Sendai virus infected cells, Baum et al. determined preferred binding of DI genomes to RIG-I ([@bib0045]).

It appears plausible that the genomic RNA should be targeted by RIG-I, primarily. Actually, purified genomic RNA from most examined (−)ssRNA viruses like Rabies virus ([@bib0240]), Lassa virus, Nipah virus, Rift Valley fever virus ([@bib0215]) activated RIG-I. Nevertheless, RNA purification by denaturating agents removes RNA-interacting viral nuclear proteins, allowing formation of secondary RIG-I-activating RNA structures which do not occur *in vivo* (*e.g.* hybridization of (−)ssRNA and (+)ssRNA). Therefore it is uncertain if these viral genomes would activate RIG-I during infection. However, the phenomenon that (−)ssRNA viruses possess mechanisms to modify their genomic 5′end, preventing RIG-I recognition ([@bib0215], [@bib0435]), implies that the dsRNA structures that (can) form at the 5′end of viral genomes are critical for the viruses with RIG-I escape mechanisms (Arenaviridae, Bunyaviridae, Bornaviridae).

In fact, the principle of detecting panhandle structures represents an intelligent strategy to detect (−)ssRNA viruses because replication of (−)ssRNA viruses necessitates highly conserved promoters at both ends of the genome, consequently yielding self-complementary 5′ and 3′ ends. The intolerance of VSV for artificially introduced extra nucleotides at the 5′ and 3′ ends of its (−)ssRNA genome suggests lack of flexibility of (−)ssRNA viruses concerning promoter sequences ([@bib0505]). Therefore, a blunt-ended double-stranded RNA structure with 5′triphosphate, the consequence of two conserved promoters, constitutes a negative strand virus-associated molecular pattern recognized by RIG-I.

Correctly processed viral mRNA is unlikely to be targeted by RIG-I, because RNA viruses possess mechanisms to cap their mRNA either by viral-encoded capping enzymes or cap-snatching mechanisms ([@bib0165]) leading to loss of, or masking of the 5′triphosphate. Nevertheless, other studies suggest that type I IFN induction by Mononegavirales (*e.g.* SeV, VSV, MeV) is associated with mRNA transcription rather than replication (reviewed in [@bib0195]). *E.g.*, in contrast to Influenza, replication-disabled Measles virus that was still capable of transcription was observed to still activate a type I IFN response ([@bib0530]). Leader and trailer RNAs (leRNA and trRNA) represent the only non-capped 5′triphosphorylated transcripts occurring during the transcription of the genome. Plumet et al. and Bitko et al. observed (−)ssRNA virus LeRNA dependent stimulation of RIG-I ([@bib0070], [@bib0530]). However, the viral RNA which forms together with the LeRNA the RIG-I activating dsRNA species still needs to be determined. Gerlier and Lyles proposed that L-trRNA read-through transcripts (viral L-mRNA extended by the trRNA template) hybridized to ppp-trRNA could also reconstitute a source of perfect blunt-ended RIG-I target structures during the non-replicative transcription phase ([Fig. 1](#fig0005){ref-type="fig"}, left panel) ([@bib0195]).

### DNA viruses {#sec0090}

DNA genome-based viruses like Adenovirus, vaccinia virus and Herpesviridae (Herpes simplex virus, HSV) generate copious amounts of dsRNA during their life cycle ([@bib0735]); these dsRNAs are most probably generated by overlapping converging transcription ([@bib0275]). While Melchjorsen et al. reported MDA5 but not RIG-I-dependent type I IFN induction by HSV1 ([@bib0450]), Xing et al. reported that the HSV1 encoded US11 protein interacts with and inhibits both RIG-I and MDA5, indicating that HSV1-derived RNA is also recognized by RIG-I ([@bib0760]). Finally, EBV and Adenovirus-encoded small RNA polymerase III transcripts (EBER and VAI) were described to activate RIG-I ([@bib0010], [@bib0460], [@bib0580]).

Concluding remarks {#sec0095}
==================

Despite the presence of crystal data, conflicting results on ligand motif definition still obscure the understanding of MDA5 pathogen RNA detection. As demonstrated for Paramyxoviruses, conclusions from studies testing immune responses in RIG-I/MDA5 knock-out cells to whole viruses can be misleading as long as the function of viral proteins is unknown: viruses appear to be recognized by RIG-I because they express proteins efficiently inhibiting MDA5, and the opposite is also thinkable. By contrast, recent progress in the synthesis and purification of defined synthetic ligands, native preparation and visualization of natural RIG-I ligands (nucleocapsids) and crystallization of RIG-I/ligand complexes has greatly improved the understanding of the molecular basis of RIG-I-dependent virus recognition. Most of the studies agree on terminal base pair recognition by RIG-I, which is dependent on the presence of 5′triphosphate in a physiological relevant ligand concentration range. Completely end base pair-independent RIG-I recognition as proposed for long (≥100 bp) dsRNA needs further investigation since it can currently not be explained by the model derived from recent crystal data. Naturally occurring RIG-I ligands are double stranded triphosphorylated replicative intermediates of (+)ssRNA viruses (formal scientific proof is missing though) and the triphosphorylated panhandle structures of genomes of (−)ssRNA viruses with the exception of Mononegavirales, which are able to avoid forming panhandle structures *in vivo*. Other viruses avoid RIG-I recognition by laborious procedures leading to 5′overhangs or 5′monophosphorylation. Interestingly, in analogy to phage polymerases *in vitro*, RNA polymerases of *Mononegavirales* generate RIG-I ligands due to an error-prone transcription process, therefore counteracting their -- in principle -- perfect camouflage against RIG-I recognition.

On the other hand, a successful virus has to protect its host from detrimental consequences of infection. The best examples are Herpesviruses, the infection of which usually proceeds asymptomatic: \>95% of adults are, for example, infected by EBV, which persists lifelong in its host without causing detrimental symptoms, making EBV a very successful virus ([@bib0700]). EBV is known for its close interaction with the immune system, limiting its own infection in the host ([@bib0700]). Thus immune recognition of the virus at a certain stage of its spread in the host should be evolutionarily favored and complete immune evasion not the goal of virus adaption.
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